Skip to content
Is the accelerated approval pathway helping patients achieve better health outcomes or imposing on society medicines that don’t work? In BIO’s view, the pathway […]
Setting the record straight on accelerated approval Read More »
Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions Committee, announced that he is launching an investigation into the pricing
On April 18, BIO’s inaugural Agriculture & Environment Summit brought together bipartisan policymakers who emphasized the promise of innovation to address key challenges such
BIO Agriculture & Environment Summit brings together bipartisan policymakers, regulators Read More »
A recent human infection of avian flu in Texas, coming just days after the first infections of U.S. livestock, has spurred research into the
Biotech and One Health are key to controlling avian flu Read More »
Clear laws giving intellectual property rights to human inventors who use artificial intelligence will allow us to take advantage of the remarkable advances AI
People invent things – AI just helps, biotech IP expert tells Congress Read More »
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments.
Heart disease patients and the IRA’s misguided incentives Read More »
The COVID-19 pandemic laid bare the vulnerabilities of global supply chains, especially in the biopharmaceutical sector. “Nobody ever could have envisioned a global pandemic
Why building America’s biomanufacturing sector is critical for America’s security Read More »
President Biden delivered his third State of the Union address last night, March 7. Health care was a prominent theme throughout the night, which
Key takeaways from the State of the Union address Read More »
When it comes to science and biotech, the gender gap between men and women still persists. The UNESCO Science Report Towards 2030 in 2015
Women’s History Month: 12 women in science and biotech to know Read More »
On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome
As White House prepares ‘listening session’ on PBMs, here’s what they need to hear Read More »
